Breast Awareness, Self-Reported Abnormalities, and Breast Cancer in Rural Ethiopia: A Survey of 7,573 Women and Predictions of the National Burden.
Breast neoplasms
Ethiopia
Health services
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
11
11
2020
accepted:
29
01
2021
pubmed:
3
3
2021
medline:
6
7
2021
entrez:
2
3
2021
Statut:
ppublish
Résumé
Breast cancer (BC) is the most frequently diagnosed cancer and leading cause of cancer deaths among women in low-income countries. Ethiopia does not have a national BC screening program, and over 80% of patients are diagnosed with advanced stage disease. The aim of this study was to assess how many women self-report a breast abnormality and to determine their diagnoses in rural Ethiopia. A community-based cross-sectional study was conducted among 7,573 adult women. Women were interviewed and educated about breast awareness, and those who reported breast abnormalities underwent clinical examination by experienced surgeons. Ultrasound-guided fine needle aspiration cytology (FNAC) was obtained, and cytological analysis was performed. The findings were projected to the female population of Ethiopia to estimate current and future burden of diseases. Of the 7,573 women surveyed, 258 (3.4%) reported a breast abnormality, 246 (3.2%) received a physical examination, and 49 (0.6%) were found to be eligible for ultrasound-guided FNAC or nipple discharge evaluation. Of all the cases, five (10.2%) breast malignancies were diagnosed. We projected for Ethiopia that, approximately, 1 million women could self-report a breast abnormality, 200,000 women could have a palpable breast mass, and 28,000 women could have BC in the country. The health care system needs to build capacity to assess and diagnose breast diseases in rural areas of Ethiopia. These data can be used for resource allocation to meet immediate health care needs and to promote detecting and treating BC at earlier stages of disease. Routine mammography screening in a resource-limited country with a young population is neither sensitive nor affordable. Clinical breast examination with consecutive ultrasound-guided fine needle aspiration cytology may ensure early diagnosis, downstage disease, and reduce breast cancer mortality. This study had the unique opportunity to educate over 7,573 rural women about breast abnormalities and offer clinical and cytological diagnosis for reported breast abnormalities. The findings were extrapolated to show the nationwide burden of breast abnormalities and unmet diagnostic needs. These data will serve as policy guide to improve adequate referral mechanisms and breast diagnostic and treatment facilities.
Sections du résumé
BACKGROUND
Breast cancer (BC) is the most frequently diagnosed cancer and leading cause of cancer deaths among women in low-income countries. Ethiopia does not have a national BC screening program, and over 80% of patients are diagnosed with advanced stage disease. The aim of this study was to assess how many women self-report a breast abnormality and to determine their diagnoses in rural Ethiopia.
METHODS
A community-based cross-sectional study was conducted among 7,573 adult women. Women were interviewed and educated about breast awareness, and those who reported breast abnormalities underwent clinical examination by experienced surgeons. Ultrasound-guided fine needle aspiration cytology (FNAC) was obtained, and cytological analysis was performed. The findings were projected to the female population of Ethiopia to estimate current and future burden of diseases.
FINDINGS
Of the 7,573 women surveyed, 258 (3.4%) reported a breast abnormality, 246 (3.2%) received a physical examination, and 49 (0.6%) were found to be eligible for ultrasound-guided FNAC or nipple discharge evaluation. Of all the cases, five (10.2%) breast malignancies were diagnosed. We projected for Ethiopia that, approximately, 1 million women could self-report a breast abnormality, 200,000 women could have a palpable breast mass, and 28,000 women could have BC in the country.
CONCLUSION
The health care system needs to build capacity to assess and diagnose breast diseases in rural areas of Ethiopia. These data can be used for resource allocation to meet immediate health care needs and to promote detecting and treating BC at earlier stages of disease.
IMPLICATIONS FOR PRACTICE
Routine mammography screening in a resource-limited country with a young population is neither sensitive nor affordable. Clinical breast examination with consecutive ultrasound-guided fine needle aspiration cytology may ensure early diagnosis, downstage disease, and reduce breast cancer mortality. This study had the unique opportunity to educate over 7,573 rural women about breast abnormalities and offer clinical and cytological diagnosis for reported breast abnormalities. The findings were extrapolated to show the nationwide burden of breast abnormalities and unmet diagnostic needs. These data will serve as policy guide to improve adequate referral mechanisms and breast diagnostic and treatment facilities.
Identifiants
pubmed: 33650727
doi: 10.1002/onco.13737
pmc: PMC8176994
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1009-e1017Informations de copyright
© 2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press.
Références
J Glob Oncol. 2018 Sep;4:1-11
pubmed: 30241262
Lancet Oncol. 2013 Apr;14(4):363-70
pubmed: 23375833
BMC Womens Health. 2020 Feb 27;20(1):38
pubmed: 32103774
J Natl Compr Canc Netw. 2016 May;14(5):527-36
pubmed: 27160231
J Oncol. 2010;2010:595167
pubmed: 21253541
J Ultrasound. 2011 Dec;14(4):182-7
pubmed: 23396986
Prev Med. 2011 Sep;53(3):118-20
pubmed: 21596057
Ann Intern Med. 2009 Nov 17;151(10):727-37, W237-42
pubmed: 19920273
Dtsch Arztebl Int. 2008 Feb;105(8):131-6
pubmed: 19633778
BMC Public Health. 2018 Apr 4;18(1):447
pubmed: 29615015
Breast J. 2006 Jan-Feb;12 Suppl 1:S3-15
pubmed: 16430397
Oncologist. 2016 May;21(5):571-5
pubmed: 27009935
PLoS One. 2017 Feb 13;12(2):e0171024
pubmed: 28192444
Breast Care (Basel). 2008;3(1):21-27
pubmed: 20824016
J Surg Res. 2016 Jul;204(1):61-7
pubmed: 27451869
Cancer Epidemiol. 2018 Apr;53:93-98
pubmed: 29414637
JAMA. 2014 Apr 2;311(13):1327-35
pubmed: 24691608
Springerplus. 2015 Oct 15;4:615
pubmed: 26543750
Indian J Palliat Care. 2015 May-Aug;21(2):198-202
pubmed: 26009674
J Surg Oncol. 2014 Dec;110(8):903-6
pubmed: 25088235
BMJ Open. 2019 Nov 11;9(11):e032228
pubmed: 31719089
Oncologist. 2016 Sep;21(9):1138-48
pubmed: 27401898
BMC Cancer. 2012 Jan 25;12:41
pubmed: 22277164
Cancer. 1993 Sep 1;72(5):1642-51
pubmed: 8348496
Cochrane Database Syst Rev. 2011 Jan 19;(1):CD001877
pubmed: 21249649
Breast Cancer Res Treat. 2021 Jan;185(1):117-124
pubmed: 32948993
BMC Cancer. 2019 Apr 25;19(1):393
pubmed: 31023270
Oncologist. 2016 Jun;21(6):739-44
pubmed: 27091419
Int J Cancer. 2014 Aug 1;135(3):702-9
pubmed: 24375396